Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Analyst Buy
|
Mid-range Performer
1154.8000
31.00
(
2.76
%)
NSE
Nov 10, 2025
15:31 PM
Volume:
1.4M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
07 Nov 2025
Analyst Buy
1154.80
2.76%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1345 | Upside : 16.5%
Target
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
Number of FII/FPI investors decreased from 728 to 700 in Sep 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
IPO market heats up: Physicswallah and six others to open, five listings this week
|
10 Nov 2025, 05:36PM
Market closes higher, KPIT Technologies' Q2 revenue beats Forecaster estimates by 3%
Trendlyne Marketwatch |
10 Nov 2025, 03:59PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020